1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Daniela A. Bota: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma NOVOTTF-200A - Astrocytoma, Grade III | Not applicable | Completed | Daniela A. Bota | 1 | 2020-05-21 | 2026-02-17 |
Astrocytoma (1)
United States (1)
Daniela Bota, MD (1)